No idea Aditya. I don’t track the company. But just in reviewing the standalone and consolidated EPS:
Barring the last year (’15), for the rest of the years the consolidated EPS seems to be higher than standalone EPS and
The anaemic growth is apparent whether seen in standalone or consol figures.
I agree Angad. Any idea on how the subsidiaries are doing? I think most of them being in mature markets are the culprit for TGBL’s lacklustre EPS growth
thanks Abhishek for the clarification.
After the announcement in Apr 2015 regd issue of warrants I stopped tracking the company.
I agree that issue of warrants at 200 to non-promoter is a green flag.
However, there must be something wrong with the FII Polus Global to subscribe to warrants at Rs 200 when the stock was quoting at around Rs 130 in Sept ( and at lesser price prior to that) . Why not buy from open market ?
Strides had sent this reply to BSE, on the Mylan claim news
http://www.bseindia.com/corporates/ann.aspx?scrip=532531&dur=A&expandable=0
point number 5 is the important gist out of this note
Ranvir – I am not based in India so I cannot tell. But I have seen quite a few of their outlets in Mumbai and Delhi – all at prime places. Rentals are likely to be much higher than your estimate (but so could the revenues). Even generally, Tata global’s (consolidated) EPS has been the following:
2007: 7.5
2008: 24.9
2009: 11.3
2010: 6.3
2011: 4.1
2012: 5.8
2013: 6.0
2014: 7.8
2015: 4.0
They have outstanding shares of 63cr. Even with your profit estimate of 150cr. (in a few years) for Tata Global from the Starbucks franchise, that will hardly move the needle by Rs 2.5 per share. In a company that hasn’t shown any EPS growth over the last few years, just this alone doesn’t look like a very compelling reason to invest – just looking at the numbers.
The string itself suggests that this is a discussion on your portfolio, so obviously it is entirely your call but all investment must be done with full DD.
Best.
Summit securities holding company of CEAT,ZENSAR,KEC,RPGLIFE current quoted holding value 3000 crore and un quoted 50% stake in spencer hotels value 500cr this company is zero debit company and strong pramoter stakeof 73% market cap 340 Cr only means trading at 90% discount to its fair value . Generally holding companies will trade at 50-60% discount like jsw holdings, Bajaj holdings etc .
I think its a good investment idea to buy premium companies at discounted price of 90%
Well how god or bad greed is…just one coverage and UC for stock…WOW
Well how god or bad greed is…just one coverage and UC for stock…WOW
Thanks anindya for the explanation about generics and branded generics.
In India, typically most pharma companies market their own brands and can be termed as branded generics.
Nowadays some cities have started seeing pure generics medical shops but I think until doctors embrace the concept of prescribing generic drugs, mainly by their generic names rather than brand names, this trend of growth in generics is unlikely to catch up.
Coming to Alkem, it seems a company similar to the likes of Torrent Pharma, ajanta, Intas, and the rest of the lot. It does have a dominant place in antibiotics therapy. And much is talked about its US prospects though I dont know much about it.
Personally I would like to wait some time and know more about the company before taking a call.
Hi @manish26 here you answer regarding GST.
I think it will benefit textile industry